HIV integrase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514533, 560 70, C07C 6984, A61K 31235

Patent

active

061243272

ABSTRACT:
Natural products such as certain dimerized hydroxyphenylundecanes are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

REFERENCES:
patent: 5759842 (1998-06-01), Dombrowski et al.
LaFemina et al., Antimicrobial Agents & Chemotherapy, vol. 39(2), pp. 320-324 (1995), "Inhibition of human immunodeficiency virus integrase by bis-catechols".
Cushman et al., J. Med. Chem., vol. 38 (1995), pp.443-452, "Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase".
Mazumder et al., Biochemistry, vol. 34 (1995), pp. 15111-15122, "Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase".
Mazumder et al., J. Med. Chem., vol. 39 (1996), pp 2472-2481, "Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease".
Mazumder et al., Molecular Pharmacology, vol. 49 (1996), pp. 621-628, "Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase".
Zhao et al., J. Med. Chem., vol. 40 (1997), pp. 937-941, "Hydrazide-containing inhibitors of HIV-1 integrase".
Mazumder et al., AIDS Research and Human Retroviruses, vol. 11(1), pp. 115-125 (1995), "Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation . . . "
Mazumder et al., Proc. Nat'l Acad. Sci. USA, vol. 91, pp. 5771-5775 (1994), "Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate".
Carteau et al., Archives of Biochemistry & Biophysics, vol. 305(2), pp. 606-610 (1993), "Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction".
Fesen et al., Proc. Nat'l Acad. Sci. USA, vol. 90 (1993), pp. 2399-2403, "Inhibitors of human immunodeficiency virus integrase".
Farnet et al., Proc. Nat'l Acad. Sci. USA, vol. 93 (1996), pp. 9742-9747, "Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules".
Lutzke et al., Proc. Nat'l Acad. Sci. USA, vol. 92 (1995), pp. 11456-11460, "Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library".
Ojwang et al., Antimicrobial Agents & Chemotherapy, vol. 39(11), pp. 2426-2435 (1995), "T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor . . . "
Eich et al., J. Med. Chem., vol. 39 (1996), pp. 86-95, "(+)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase".
Robinson, Jr., et al., Proc. Nat'l Acad. Sci. USA, vol. 93 (1996), pp. 6326-6331, "Inhibitors of HIV-1 replication that inhibit HIV integrase".
PRNewswire, Sep. 17, 1996, "Aronex reports results for lead anti-HIV integrase inhibitor compound".
Neamati et al., "Design and discovery of HIV-1 integrase inhibitors", DDT2(11) (1997), pp. 487-498.
Hazuda et al., Nucleic Acids Research, vol. 22 (6), pp. 1121-1122 (1994), "A novel assay for the DNA strand-transfer reaction of HIV-1 integrase".
Burke et al., J. Med. Chem., vol. 38 (1995), pp. 4171-4178, "Hydroxylated aromatic inhibitors of HIV-1 integrase".
Hazuda et al., J. of Virology, vol. 71(1), ppl 807-811 (1997), "Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds".
Fesen et al., Biochemical Pharma., vol. 48(3), pp. 595-608 (1994), "Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (cape) and related compounds".
Zhao et al., J. Med. Chem., vol. 40 (1997), pp. 1186-1194, "Arylamide inhibitors of HIV-1 integrase".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2100620

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.